• Skip to primary navigation
  • Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Case reports
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • BC Issues until 2024
  • Submission
  • Istruction for authors
  • Search

DOCUMENTI SIBIOC - SIBioC Documents

Volume:

Biochimica Clinica 2018; 42(1) 74-78

Published on-line:

February 2, 2018

DOI:

10.19186/BC_2018.010

Download in PDF:
Authentication required

Determinazione delle immunoglobuline E specifiche

AUTHORS

Diego Faggian1, Ignazio Brusca2, Barbara Cinti3, Beatrice Caruso4, Bruno Dente5, Maria Grazia Mazzarello6, Tiziana Scacchetti7 per il Gruppo di Studio SIBioC “Allergologia di Laboratorio”
1U.O.C. Medicina di Laboratorio, Azienda Ospedaliera-Università di Padova
2U.O di Patologia Clinica, P.O. Buccheri La Ferla, Palermo
3Laboratorio Analisi, A.O.U. Ospedali Riuniti, Ancona
4Laboratorio di Biochimica Clinica, Università di Verona
5U.O.C. Medicina di Laboratorio, P.O. San Paolo, Napoli
6Laboratorio Analisi, P.O. Novi Ligure (AL)
7Dipartimento di Patologia Clinica, Ospedale Sant’Agostino Estense-NOCSAE Baggiovara, Modena

ABSTRACT

SIBioC Position statement about in vitro immunoglobulin E (IgE) testing

The aim of this document is to contribute to increase the knowledge of the diagnostic significance and the clinical value of laboratory tests that are included in the in vitro category of allergy tests. In this context, the clinical benefits of the in vitro determination of specific immunoglobulins E (IgE) for complete extracts or single allergen molecules is to be strongly reaffirmed. This test is to be consider central in the diagnostic algorithm of allergic diseases compared to Skin Prick Test.

REFERENCES